Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
5.77M
-
Shares change
-
-145K
-
Total reported value, excl. options
-
$42.5M
-
Value change
-
-$1.25M
-
Put/Call ratio
-
0
-
Number of buys
-
12
-
Number of sells
-
-15
-
Price
-
$7.37
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2025
40 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2025.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.77M shares
of 13.8M outstanding shares and own 41.71% of the company stock.
Largest 10 shareholders include BATTERY MANAGEMENT CORP. (2.42M shares), NEA Management Company, LLC (1.71M shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (400K shares), VANGUARD GROUP INC (327K shares), RENAISSANCE TECHNOLOGIES LLC (181K shares), MORGAN STANLEY (131K shares), BlackRock, Inc. (121K shares), GEODE CAPITAL MANAGEMENT, LLC (75.2K shares), NORTHERN TRUST CORP (53.8K shares), and ACADIAN ASSET MANAGEMENT LLC (36.2K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.